NCT05101213 2026-04-16Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer PatientsM.D. Anderson Cancer CenterPhase 1 Recruiting30 enrolled